Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
60.81
-0.04 (-0.07%)
May 13, 2025, 4:00 PM - Market closed

Incyte Market Cap

Incyte has a market cap or net worth of $11.77 billion as of May 14, 2025. Its market cap has increased by 2.43% in one year.

Market Cap
11.77B
Enterprise Value
9.41B
1-Year Change
2.43%
Ranking
Category
Stock Price
$60.81

Market Cap Chart

Since December 1, 1998, Incyte's market cap has increased from $887.90M to $11.77B, an increase of 1,225.71%. That is a compound annual growth rate of 10.26%.

History

DateMarket Cap% Change
May 12, 202511.78B-11.48%
Dec 31, 202413.31B-5.44%
Dec 29, 202314.07B-21.25%
Dec 30, 202217.87B10.21%
Dec 31, 202116.21B-14.88%
Dec 31, 202019.05B1.27%
Dec 31, 201918.81B38.99%
Dec 31, 201813.53B-32.29%
Dec 29, 201719.99B5.81%
Dec 30, 201618.89B-6.36%
Dec 31, 201520.17B63.32%
Dec 31, 201412.35B51.41%
Dec 31, 20138.16B274.30%
Dec 31, 20122.18B14.96%
Dec 30, 20111.90B-7.01%
Dec 31, 20102.04B88.80%
Dec 31, 20091.08B193.21%
Dec 31, 2008368.30M-56.50%
Dec 31, 2007846.70M72.90%
Dec 29, 2006489.70M9.92%
Dec 30, 2005445.50M-39.62%
Dec 31, 2004737.80M48.87%
Dec 31, 2003495.60M59.97%
Dec 31, 2002309.80M-76.00%
Dec 31, 20011.29B-19.15%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 677.95B
Johnson & Johnson 371.28B
UnitedHealth Group 343.53B
AbbVie 337.40B
Novo Nordisk 292.03B
Abbott Laboratories 229.59B
Novartis AG 213.30B
AstraZeneca 210.42B
Market Cap Rankings